Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00037713
Status:
COMPLETED
Last Update Posted:
2010-04-08
First Post:
2002-05-20
Brief Title:
Survival in a Randomized Phase III Trial in Patients With Limited Disease LD Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company